Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon C Afford

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Communications Medicine|October 25, 2024
A reproducible extended ex-vivo normothermic machine liver perfusion protocol utilising improved nutrition and targeted vascular flowsGeorge Clarke, Jingwen Mao, Angus Hann, et al.
Journal of Hepatology|December 20, 2011
A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migrationGarrick K Wilson, Claire L Brimacombe, Ian A Rowe, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 7, 2021
Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High-Risk Donor LiversHynek Mergental, Richard W Laing, James Hodson, et al.
BMJ Open|November 30, 2017
Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trialRichard W Laing, Hynek Mergental, Christina Yap, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 26, 2018
Development of Clinical Criteria for Functional Assessment to Predict Primary Nonfunction of High-Risk Livers Using Normothermic Machine PerfusionHynek Mergental, Barnaby T F Stephenson, Richard W Laing, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 25, 2018
The Reactive Oxygen Species-Mitophagy Signaling Pathway Regulates Liver Endothelial Cell Survival During Ischemia/Reperfusion InjuryRicky H Bhogal, Christopher J Weston, Susanne Velduis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 18, 2023
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomesHynek Mergental, Richard W Laing, Amanda J Kirkham, et al.
Nature Communications|June 18, 2020
Transplantation of discarded livers following viability testing with normothermic machine perfusionHynek Mergental, Richard W Laing, Amanda J Kirkham, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Communications Medicine|October 25, 2024
A reproducible extended ex-vivo normothermic machine liver perfusion protocol utilising improved nutrition and targeted vascular flowsGeorge Clarke, Jingwen Mao, Angus Hann, et al.
Journal of Hepatology|December 20, 2011
A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migrationGarrick K Wilson, Claire L Brimacombe, Ian A Rowe, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 7, 2021
Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High-Risk Donor LiversHynek Mergental, Richard W Laing, James Hodson, et al.
BMJ Open|November 30, 2017
Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trialRichard W Laing, Hynek Mergental, Christina Yap, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 26, 2018
Development of Clinical Criteria for Functional Assessment to Predict Primary Nonfunction of High-Risk Livers Using Normothermic Machine PerfusionHynek Mergental, Barnaby T F Stephenson, Richard W Laing, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 25, 2018
The Reactive Oxygen Species-Mitophagy Signaling Pathway Regulates Liver Endothelial Cell Survival During Ischemia/Reperfusion InjuryRicky H Bhogal, Christopher J Weston, Susanne Velduis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 18, 2023
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomesHynek Mergental, Richard W Laing, Amanda J Kirkham, et al.
Nature Communications|June 18, 2020
Transplantation of discarded livers following viability testing with normothermic machine perfusionHynek Mergental, Richard W Laing, Amanda J Kirkham, et al.
Pageof 5